NM_004168.4:c.1752A>G

Variant names:

• chr5-251426-A-G
• rs13070
• NM_004168.4:c.1752A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_Strong BP6_Very_Strong BP7 BA1

The NM_004168.4(SDHA):​c.1752A>G​(p.Ala584Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 1,612,340 control chromosomes in the GnomAD database, including 24,109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A584A) has been classified as Likely benign.

• Frequency:
  • Genomes: 𝑓 0.24 (6866 hom., cov: 33)
  • Exomes 𝑓: 0.14 (17243 hom.)
• Consequence: SDHA NM_004168.4 synonymous
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:14
• Conservation: PhyloP100: -0.447
• Publications: 8 publications found

Genes affected

SDHA (HGNC:10680): (succinate dehydrogenase complex flavoprotein subunit A) This gene encodes a major catalytic subunit of succinate-ubiquinone oxidoreductase, a complex of the mitochondrial respiratory chain. The complex is composed of four nuclear-encoded subunits and is localized in the mitochondrial inner membrane. Mutations in this gene have been associated with a form of mitochondrial respiratory chain deficiency known as Leigh Syndrome. A pseudogene has been identified on chromosome 3q29. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]

SDHA Gene-Disease associations (from GenCC):

• hereditary pheochromocytoma-paraganglioma

  Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
• pheochromocytoma/paraganglioma syndrome 5

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
• mitochondrial complex II deficiency, nuclear type 1

  Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
• neurodegeneration with ataxia and late-onset optic atrophy

  Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
• Leigh syndrome

  Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
• familial isolated dilated cardiomyopathy

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• gastrointestinal stromal tumor

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• Leigh syndrome with leukodystrophy

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
• mitochondrial complex II deficiency

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
• dilated cardiomyopathy 1GG

  Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

ENSG00000286001 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -21 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.75).
• BP6: Variant 5-251426-A-G is Benign according to our data. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-251426-A-G is described in CliVar as Benign. Clinvar id is 130277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BP7: Synonymous conserved (PhyloP=-0.447 with no splicing effect.
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.52 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
SDHA	NM_004168.4	c.1752A>G	p.Ala584Ala	synonymous_variant	Exon 13 of 15	ENST00000264932.11	NP_004159.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
SDHA	ENST00000264932.11	c.1752A>G	p.Ala584Ala	synonymous_variant	Exon 13 of 15	1	NM_004168.4	ENSP00000264932.6
ENSG00000286001	ENST00000651543.1	n.*485A>G		non_coding_transcript_exon_variant	Exon 12 of 24			ENSP00000499215.1
ENSG00000286001	ENST00000651543.1	n.*485A>G		3_prime_UTR_variant	Exon 12 of 24			ENSP00000499215.1

Frequencies

GnomAD3 genomes AF: 0.240 AC: 36504 AN: 151962 Hom.: 6838 Cov.: 33

Gnomad AFR AF: 0.525

Gnomad AMI AF: 0.306

Gnomad AMR AF: 0.220

Gnomad ASJ AF: 0.165

Gnomad EAS AF: 0.0561

Gnomad SAS AF: 0.0889

Gnomad FIN AF: 0.0817

Gnomad MID AF: 0.206

Gnomad NFE AF: 0.125

Gnomad OTH AF: 0.233

GnomAD2 exomes AF: 0.151 AC: 37847 AN: 250352 AF XY: 0.142

Gnomad AFR exome AF: 0.545

Gnomad AMR exome AF: 0.188

Gnomad ASJ exome AF: 0.163

Gnomad EAS exome AF: 0.0602

Gnomad FIN exome AF: 0.0858

Gnomad NFE exome AF: 0.127

Gnomad OTH exome AF: 0.149

GnomAD4 exome AF: 0.137 AC: 199524 AN: 1460260 Hom.: 17243 Cov.: 32 AF XY: 0.134 AC XY: 97380 AN XY: 726562

⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.

African (AFR) AF: 0.544 AC: 18104 AN: 33292

American (AMR) AF: 0.188 AC: 8375 AN: 44632

Ashkenazi Jewish (ASJ) AF: 0.165 AC: 4296 AN: 26112

East Asian (EAS) AF: 0.0480 AC: 1905 AN: 39690

South Asian (SAS) AF: 0.0902 AC: 7773 AN: 86194

European-Finnish (FIN) AF: 0.0884 AC: 4719 AN: 53392

Middle Eastern (MID) AF: 0.138 AC: 797 AN: 5758

European-Non Finnish (NFE) AF: 0.130 AC: 144189 AN: 1110904

Other (OTH) AF: 0.155 AC: 9366 AN: 60286

⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.

GnomAD4 genome AF: 0.241 AC: 36578 AN: 152080 Hom.: 6866 Cov.: 33 AF XY: 0.235 AC XY: 17459 AN XY: 74356

African (AFR) AF: 0.526 AC: 21764 AN: 41410

American (AMR) AF: 0.220 AC: 3364 AN: 15292

Ashkenazi Jewish (ASJ) AF: 0.165 AC: 574 AN: 3472

East Asian (EAS) AF: 0.0556 AC: 288 AN: 5178

South Asian (SAS) AF: 0.0891 AC: 430 AN: 4824

European-Finnish (FIN) AF: 0.0817 AC: 866 AN: 10602

Middle Eastern (MID) AF: 0.211 AC: 62 AN: 294

European-Non Finnish (NFE) AF: 0.125 AC: 8467 AN: 67984

Other (OTH) AF: 0.229 AC: 484 AN: 2112

Alfa AF: 0.182 Hom.: 1673

Bravo AF: 0.268

Asia WGS AF: 0.114 AC: 400 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:14

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:3

Jan 03, 2020

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Mar 03, 2015

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

not specified Benign:2

-

Genetic Services Laboratory, University of Chicago

Significance: Likely benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-

PreventionGenetics, part of Exact Sciences

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Pheochromocytoma/paraganglioma syndrome 5 Benign:2

Jul 07, 2023

KCCC/NGS Laboratory, Kuwait Cancer Control Center

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Mar 11, 2025

Myriad Genetics, Inc.

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Hereditary cancer-predisposing syndrome Benign:2

Nov 18, 2014

Ambry Genetics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 08, 2025

Hereditary Cancer Laboratory, Hospital Universitario 12 de Octubre

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

BA1+BP6+BP7 -

Mitochondrial complex II deficiency, nuclear type 1 Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Leigh syndrome Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Pheochromocytoma/paraganglioma syndrome 5;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Benign:1

Feb 04, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Dilated cardiomyopathy 1GG;C3279992:Pheochromocytoma/paraganglioma syndrome 5;C5543254:Neurodegeneration with ataxia and late-onset optic atrophy;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Benign:1

Apr 08, 2024

Department of Pathology and Laboratory Medicine, Sinai Health System

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Hereditary pheochromocytoma-paraganglioma Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.75
CADD	Benign	1.6
DANN	Benign	0.47
PhyloP100		-0.45
PromoterAI		-0.028	Neutral
RBP_binding_hub_radar		0.92
RBP_regulation_power_radar		2.7
Mutation Taster		=99/1	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs13070; hg19: chr5-251541; COSMIC: COSV53765948; COSMIC: COSV53765948;